Bionano Genomics (BNGO) Change in Cash (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Change in Cash data on file, last reported at $403000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 106.78% year-over-year to $403000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 110.27% YoY), and the FY2025 full-year result was -$5.1 million, up 42.29% from the prior year.
• Change in Cash fell to $403000.0 in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $19.7 million in Q3 2023 to a low of -$22.7 million in Q4 2022.
• A 5-year average of -$1.2 million and a median of -$63000.0 in 2025 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 1857.5% in 2023 and tumbled 171.72% in 2025, its largest moves.
• Tracing BNGO's Change in Cash over 5 years: stood at -$22.7 million in 2022, then increased by 26.7% to -$16.6 million in 2023, then soared by 102.28% to $379000.0 in 2024, then soared by 281.0% to $1.4 million in 2025, then sank by 72.09% to $403000.0 in 2026.
• Business Quant data shows BNGO's Change in Cash at $403000.0 in Q1 2026, $1.4 million in Q4 2025, and -$497000.0 in Q3 2025.